Reductions in occipital cortex GABA levels in panic disorder detected with 1H-magnetic resonance spectroscopy

Archives of General Psychiatry

Volumn 58, Issue 6, 2001, Pages 556-561

  Goddard, Andrew W ^a   Mason, Graeme F ^a,b   Almai, Ahmad ^a   Rothman, Douglas L ^a   Behar, Kevin L ^a   Petroff, Ognen A C ^a   Charney, Dennis S ^c   Krystal, John H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; HOMOCARNOSINE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OCCIPITAL CORTEX; PANIC; PATHOPHYSIOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0034998461     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.58.6.556     Document Type: Article

References (42)

1. Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions
2. GABAergic influences on plus-maze behaviour in mice
3. Effect of the GABA-transaminase inhibitor vigabatrin on exploratory behaviour in socially isolated rats
4. Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls
5. Plasma levels of γ-aminobutyric acid and panic disorder
6. Cerebrospinal fluid γ-aminobutyric acid in patients with panic disorder
7. Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene cf γ-aminobutyric acid type A receptors
8. A receptor clustering results in enhanced anxiety and a bias for threat cues
9. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: Preliminary results from a quantitative PET study
10. Relationships between trait and state anxiety and the central benzodiazepine receptor: A PET study
11. Brain benzodiazepine binding sites in panic disorder
12. Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENILSPECT: A preliminary report
13. Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT
14. Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder
15. SPECT-[1-123] iomazenil measurement of the benzodiazepine receptor in panic disorder
16. 1H NMR measurements of γ amino butyric acid in human brain in vivo
17. Low brain GABA level is associated with poor seizure control
18. Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients
19. Reduced cortical γ-aminobutyric acid levels in depressed patients determined by 1H-magnetic resonance spectroscopy
20. Multicenter collaborative panic disorder severity scale
21. The assessment of anxiety states by rating
22. Reliability and validity of the symptoms of major depressive illness
23. A rating scale for depression
24. Consistencies and discrepancies in self- and observer-rated anxiety scales
25. Improvements on an in vivo automatic shimming method [FASTERMAP]
26. Absolute quantitation of water and metabolites in the human brain, II: Metabolite concentrations
27. The anxiolytic-like effects of the neurosteroid allopregnanolone: Interactions with GABA(A) receptors
28. GABA dysregulation in premenstrual dysphoric disorder
29. T1-based segmentation of brain tissue with a surface coil
30. Homocarnosine and the measurement of neuronal pH in patients with epilepsy
31. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures
32. Postmortem changes of amino acid compounds in human and rat brain
33. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy
34. The rate of turnover of cortical GABA from [1-13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA)
35. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy
36. Topiramate increases cerebral GABA in healthy humans
37. Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy
38. Cortical GABA differs in unipolar and bipolar depression